Kemp Dolliver

Kemp Dolliver

Company: Brookline Capital Markets

Job title: Director - Research and Senior Analyst


Evaluating the Market Potential of New Radiopharmaceutical Therapies 3:45 pm

Assess the commercial viability of isotopes like copper-67, and lead-212 Explore investment trends and venture capital funding in CDMOs to diversify product offerings Identify strategic partnerships and licensing opportunities to secure sustainable supply chains for new therapiesRead more

day: Conference Day Two

Evaluating the Commercial & Pharmaceutical Viability of Radioisotopes to Benchmark Potential 8:00 am

This workshop will focus on assessing the commercial and pharmaceutical viability of new isotopes in radiopharmaceutical production. Participants will explore the challenges and strategies for bringing isotopes actinium-225, lutetium-177, lead-212 and copper-67 to market. This workshop will cover: Assessing Market Demand and Commercial Viability: Examine the market demand for new isotopes by analyzing therapeutic potential,…Read more

day: Pre-Conference Workshop Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.